Evidence map›Paper›PMID 39556160›Full record

ReviewReviews in endocrine & metabolic disorders2025

Meal replacement therapy for obesity and diabetes remission: efficacy assessment and considerations of barriers and facilitators to adherence among U.S. individuals with low economic resources.

Claudia G Durbin, Ainsley Hutchison, Talia Colecchi, Jennifer Mulligan, Sreevidya Bodepudi, Markella V Zanni, Chika Vera Anekwe

Abstract readReview
PubMed Publisher
In one paragraph

Review in Reviews in endocrine & metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Claudia G DurbinNYU Grossman School of Medicine, New York, NY, USA.
Ainsley HutchisonBoston University, Boston, MA, USA.
Talia ColecchiUniversity of Massachusetts, Amherst, MA, USA.
Jennifer MulliganDepartment of Medicine, Division of Endocrinology, Metabolism Unit, Massachusetts General Hospital, MGH Weight Center, 50 Staniford Street, Suite 430, Boston, MA, 02114, USA.
Sreevidya BodepudiDepartment of Medicine, Division of Endocrinology, Metabolism Unit, Massachusetts General Hospital, MGH Weight Center, 50 Staniford Street, Suite 430, Boston, MA, 02114, USA.
Markella V Zanni *Harvard Medical School, Boston, MA, USA.
Chika Vera Anekwe *Department of Medicine, Division of Endocrinology, Metabolism Unit, Massachusetts General Hospital, MGH Weight Center, 50 Staniford Street, Suite 430, Boston, MA, 02114, USA. canekwe@mgh.harvard.edu.ORCID 0000-0002-4168-5195

Funding

ROLE OF DIETARY CONSTITUENTS ON GENE EXPRESSION IN INTESTINAL EPITHELIUMP30DK040561 · MASSACHUSETTS GENERAL HOSPITAL · 1994 to 2025
$6.0M
NIDDK NIH HHS P30 DK040561
6 · The paper itself

Abstract

Individuals in the United States with lower economic resources face a disproportionate burden of obesity and co-morbid conditions. This review summarizes the efficacy of MR programs for the treatment of obesity and diabetes and alerts clinicians to potential barriers and facilitators to the uptake of such programs so they may tailor their prescriptive approach. Implementation of effective behavioral and lifestyle interventions for obesity and diabetes in low-income settings is fraught with barriers and under-studied. The dearth of data on the use of MR programs in populations with low economic resources highlights a key area for future investigation.

Indexed as

Diabetes MellitusDiabetes Mellitus, Type 2ObesityPatient ComplianceHumansPovertyUnited StatesDiabetesLow incomeMeal replacementObesityWeight loss

Identifiers

PMID39556160

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.